Abdelhamid, A. M., Saber, S., Youssef, M. E., Gaafar, A. G. A., Eissa, H., Abd-Eldayem, M. A., . . . El-Fattah, E. E. A. (2022). Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application. Elsevier.
Chicago Style (17th ed.) CitationAbdelhamid, Amir Mohamed, et al. Empagliflozin Adjunct with Metformin for the Inhibition of Hepatocellular Carcinoma Progression: Emerging Approach for New Application. Elsevier, 2022.
MLA (8th ed.) CitationAbdelhamid, Amir Mohamed, et al. Empagliflozin Adjunct with Metformin for the Inhibition of Hepatocellular Carcinoma Progression: Emerging Approach for New Application. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.